Academic And Community Cancer Research United

This study is testing if a combination of two drugs, regorafenib and durvalumab, can shrink tumors in adults with high-risk liver cancer. The goal is to see if this treatment makes surgery more effective or possible. Patients receive the drugs for up to two years and are then mon…

This study is testing a personalized treatment plan for adults with early-stage Hodgkin lymphoma. It uses a PET scan after initial chemotherapy to decide if patients need additional immunotherapy. The goal is to control the cancer effectively while aiming to reduce side effects c…

This study is testing a combination of two immunotherapy drugs, nivolumab and brentuximab vedotin, for older adults or those who cannot tolerate standard chemotherapy for untreated Hodgkin lymphoma. The goal is to see how well this drug combination controls the cancer by helping …

This study is testing if a dietary supplement called PEA can relieve nerve pain, numbness, and tingling caused by chemotherapy in cancer survivors. About 88 participants who have had these symptoms for at least 3 months will take either PEA or a placebo pill for 8 weeks. Research…